drugset / Trial / NCT02702128

Preventive EXACYL® on Perioperative Bleeding During Orthognathism of Maxillary Surgery

NCT02702128

Phase 3 Completed 157 enrolled University Hospital, Lille
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Prospective, randomized, double-blind, placebo-controlled, mono center, Phase III trial to compare EXACYL in preventive with placebo on perioperatory bleeding in orthognathism surgery.

Timeline

Start
2016-01-03
Primary completion
2018-06-30
Completion
2018-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 1 g

Indications

No indication recorded.